Cargando…
Integrative Genomic Tests in Clinical Oncology
Many clinical decisions in oncology practice rely on the presence or absence of an alteration in a single genetic locus, be it a pathogenic variant in a hereditary cancer gene or activating mutation in a drug target. In addition, there are integrative tests that produce continuous variables and eval...
Autores principales: | Imyanitov, Evgeny, Sokolenko, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9656402/ https://www.ncbi.nlm.nih.gov/pubmed/36361916 http://dx.doi.org/10.3390/ijms232113129 |
Ejemplares similares
-
Molecular Diagnostics in Clinical Oncology
por: Sokolenko, Anna P., et al.
Publicado: (2018) -
Mechanisms of acquired resistance of BRCA1/2-driven tumors to platinum compounds and PARP inhibitors
por: Imyanitov, Evgeny, et al.
Publicado: (2021) -
Molecular testing for colorectal cancer: Clinical applications
por: Imyanitov, Evgeny, et al.
Publicado: (2021) -
Hereditary cancer syndromes
por: Imyanitov, Evgeny N, et al.
Publicado: (2023) -
Cancer Therapy Guided by Mutation Tests: Current Status and Perspectives
por: Aleksakhina, Svetlana N., et al.
Publicado: (2021)